By Benjamin Horney ( October 15, 2014, 5:24 PM EDT) -- The private equity owners of ConvaTec Inc. have pegged Morgan Stanley and Goldman Sachs Group Inc. to help look into a sale of the medical supply company, Reuters reported on Wednesday. According to the report, ConvaTec could be worth as much as $10 billion. Avista Capital Partners and Nordic Capital could also end up choosing to go the initial public offering route with Convatec, the report said, although neither a sale nor an IPO is expected to happen before the new year....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.